NOV 12, 2015 10:30 AM PST

Pharmacogenetics in the Clinical Laboratory: Opportunities and Challenges

C.E. CREDITS: CE
Speakers
  • Clinical Chemistry Fellow, Department of Pathology, Johns Hopkins University School of Medicine
    Biography
      Allison Chambliss, PhD is a Clinical Chemistry Fellow in the Department of Pathology at the Johns Hopkins University School of Medicine. She received her B.S. in Chemical Engineering from Virginia Tech and her PhD in Chemical & Biomolecular Engineering from Johns Hopkins University. Allison's current clinical research interests include development of rapid, targeted pharmacogenetics assays and mass spectrometry methods. Her current training areas include operation of the clinical laboratory, quality control and assurance, laboratory management, analytical methodologies, and test interferences.

    Abstract:

    Appropriate dosing of pharmaceuticals is critical to prevent sub-therapeutic efficacy or the occurrence of adverse events. However, genetic variability may significantly influence an individual’s response to a therapeutic agent. Wide genetic variability has been observed in a number of drug-metabolizing enzymes, which are responsible for the activation or inactivation of numerous drug classes. Targeted identification of specific genetic variants may assist in providing the optimal drug at the optimal dose to the correct patient. With the aid of case studies, this presentation will describe representative genetic variants that are known to influence the metabolism of commonly-prescribed medications. The presentation will also explore the current analytical platforms and challenges associated with implementing pharmacogenetic testing in a clinical laboratory environment.

    Learning Objectives:

    1. Describe the role of genetics in the metabolism of commonly-prescribed medications.
    2. Relate genotypes of frequent drug-metabolizing variants to drug activity.
    3. Discuss the advantages and disadvantages of current approaches to pharmacogenetic testing.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...